Muscle Pharm Corporation (MSLPQ)

[TheExpertHimself]

how is this gonna be a $50 stock?

There is no evidence that the company is growing revenues versus last year's $177 million yet as far as I know. Q1 was lower than last year, and the company's cash levels and inventory levels combined at the end of Q1 were worrisome according to Wynnefield and any sensible investor.

So millions of shares might need to be issued to raise capital on top of the 3.5 million shares that will be issued if the proxy statement's employee incentives plan and employee stock purchase plan pass.

So, it is hard to imagine this company being a $50 stock to me, or just a $15 stock for that sake. I believed that the stock could reach the skies in the past, but Musclepharm's poor financial performance, high executive compensation and contractual agreements with top athletes and private equity owned contract manufacturer made me think differently.